Abstract:Purpose: To further enhance the antitumor efficacy through targeted delivery, DTX loaded lipid-based-nanosuspensions (DTX-LNS) were prepared and functionalized by PEGylation or NGR modification to develop DSPE-PEG2000 modified DTX-LNS (P-DTX-LNS) or DSPE-PEG2000-NGR modified DTX-LNS (N-DTX-LNS), respectively. Methods: Based on our previous work, functionalized DTX-LNS including P-DTX-LNS and N-DTX-LNS were prepared using thin-film hydration, and then characterized. Release behavior, stability in vitro, cytotoxicity and cellular uptake of functionalized LNS were observed. To demonstrate tumor targeting efficiency of functionalized DTX-LNS, in vivo real-time and ex vivo imaging study were conducted. Furthermore, therapeutic efficacy in vivo was evaluated in an H22-bearing mice model. Results: Functionalized DTX-LNS 100-110 nm in diameter were successfully prepared and exhibited good stability under various conditions. In vitro release studies demonstrated that DTX was released from functionalized DTX-LNS steadily and reached approximately 95% at 48 hrs. Functionalized DTX-LNS showed dose-dependent cytotoxicity and time-dependent internalization in human hepatocellular liver carcinoma cells (HepG2) cells. In vivo real-time and ex vivo imaging results indicated that tumor targeting efficiencies of P-DiR-LNS and N-DiR-LNS were 29.9% and 34.3%, respectively. Moreover, evaluations of in vivo antitumor efficacy indicated that functionalized DTX-LNS effectively inhibited tumor growth with low toxicity. Conclusion: The functionalized LNS exhibited suitable particle size, nearly spherical structure, enough drug loading and great potentials for large-scale production. The results in vitro and in vivo demonstrated that functionalized LNS could realize tumor targeting and antitumor efficacy. Consequently, functionalized DTX-LNS could be expected to be used for tumor targeting therapy.

Preparation and Evaluation of RGD and TAT Co-Modified Docetaxel-Loaded Liposome

RGD(Arg-Gly-Asp) Internalized Docetaxel-Loaded Ph Sensitive Liposomes: Preparation, Characterization and Antitumor Efficacy in Vivo and in Vitro.

RGD and cell penetrating peptides co-modiifed paclitaxel loaded liposome inhibit the A549 cells

RGD-modified Ph-Sensitive Liposomes for Docetaxel Tumor Targeting.

Docetaxel Prodrug Liposomes for Tumor Therapy: Characterization, in Vitro and in Vivo Evaluation

cRGD/TAT Dual-Ligand Reversibly Cross-Linked Micelles Loaded with Docetaxel Penetrate Deeply into Tumor Tissue and Show High Antitumor Efficacy in Vivo.

Preparation and Evaluation of Lipid Emulsified Docetaxel-Loaded Nanoparticles.

Enhanced Oral Bioavailability of Docetaxel by Lecithin Nanoparticles: Preparation, in Vitro, and in Vivo Evaluation

Functionalized Docetaxel-Loaded Lipid-Based-nanosuspensions to Enhance Antitumor Efficacy in Vivo

Preparation and studies of docetaxel proliposome

Construction and Cellular Uptake Behavior of Redox-Sensitive Docetaxel Prodrug-Loaded Liposomes

Enhanced antitumor efficacy and decreased toxicity by self-associated docetaxel in phospholipid-based micelles.

A novel monomethoxy polyethylene glycol-polylactic acid polymeric micelles with higher loading capacity for docetaxel and well-reconstitution characteristics and its anti-metastasis study

Improved Anti-Triple Negative Breast Cancer Effects of Docetaxel by RGD-Modified Lipid-Core Micelles

Preparation and Evaluation in Vitro and in Vivo of Docetaxel Loaded Mixed Micelles for Oral Administration.

Irgd-Mediated Reduction-Responsive DSPE–PEG/LA–PLGA–TPGS Mixed Micelles Used in the Targeted Delivery and Triggered Release of Docetaxel in Cancer

NGR-modified Ph-Sensitive Liposomes for Controlled Release and Tumor Target Delivery of Docetaxel.

Preparation and Characterization of Cleavable PEG and TAT Peptide Co-modified Doxorubicin Liposomes

Docetaxel liposomes for lung targeted delivery: development and evaluation

Tumor-targeted Paclitaxel Delivery and Enhanced Penetration Using TAT-decorated Liposomes Comprising Redox-Responsive Poly(ethylene Glycol).

Acetic Acid Transporter-Mediated, Oral, Multifunctional Polymer Liposomes for Oral Delivery of Docetaxel.